USPTO serial 72072335
Reviewed by CopyMark Law Group
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
NADINE P FLYNN
NADINE P FLYNN LEGAL DIVISIONBRISTOL-MYERS SQUIBB COMPANY345 PARK AVENEW YORK, NY 10154-0037| Class | Description | Status | First use |
|---|---|---|---|
| 018 | PHARMACEUTICAL PREPARATION DESIGNED AS A CELLULAR ANTI-METABOLITE, WHICH WILL BE ADMINISTERED AS AN INJECTABLE LIQUID AND IN THE FORM OF AN ORAL TABLET | EXPIRED | Mar 26, 1959 |
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
| Date | Code | Event | What it means |
|---|---|---|---|
| Jul 3, 2010 | CAEX | CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9 | — |
| Feb 12, 2009 | ASGN | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | — |
| Oct 17, 2008 | CFIT | CASE FILE IN TICRS | — |
| Sep 8, 1999 | RNL2 | REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS) | The trademark registration was renewed for another 10-year term after acceptable maintenance filings. RNL1, RNL2, and RNL3 indicate which renewal cycle (first, second, or third 10-year term) was recorded. The registration remains active. |
| Jul 22, 1999 | 9.AF | REGISTERED - SEC. 9 FILED/CHECK RECORD FOR SEC. 8 | — |
| Dec 1, 1979 | REN1 | REGISTERED AND RENEWED (FIRST RENEWAL - 20 YRS) | — |